MGROF (MustGrow Biologics) Notes Receivable: $0.00 Mil (As of Mar. 2026)


MGROF MustGrow Biologics Corp MGROF
29 GF Score
Price $0.29
! 3 Warning Signs
View Full Analysis

What is MustGrow Biologics Notes Receivable?

MustGrow Biologics MGROF +0.56% 29 Notes Receivable is $0.00 Mil as of Mar. 2026. GuruFocus rates MGROF with a GF Score™ of 29/100. The stock has 3 warning signs investors should review.

MustGrow Biologics's Notes Receivable for the quarter that ended in Mar. 2026 was $0.00 Mil.


MustGrow Biologics Notes Receivable Related Terms


MustGrow Biologics Notes Receivable Historical Data

* Premium members only.

The historical data trend for MustGrow Biologics's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MustGrow Biologics Notes Receivable Chart

MustGrow Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MustGrow Biologics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MGROF
29GF Score
MustGrow Biologics Corp MGROF
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MustGrow Biologics Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
MustGrow Biologics (MGROF) has a Notes Receivable of $0.00 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on MustGrow Biologics and its competitors.
Is MustGrow Biologics' Notes Receivable too high?
MustGrow Biologics' current Notes Receivable is $0.00 Mil. Overall, MustGrow Biologics has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does MustGrow Biologics' Notes Receivable compare to CTVA and CF?
MustGrow Biologics' Notes Receivable of $0.00 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for an Agriculture company?
A good Notes Receivable depends on the Agriculture industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on MustGrow Biologics and its competitors. MustGrow Biologics's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MustGrow Biologics stock overvalued right now?
MustGrow Biologics (MGROF) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. MustGrow Biologics' overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For MustGrow Biologics (MGROF), the current Notes Receivable is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MustGrow Biologics Business Description

Other Exchanges 0C0:GermanyMGRO:Canada
Address 1005 - 201 1st Avenue South, Saskatoon, SK, CAN, S7K 1J5
MustGrow Biologics Corp is a fully integrated provider of biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. It offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers.
29GF Score

Get the complete analysis for MGROF

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.29
Price